Amphastar Pharmaceuticals (NASDAQ:AMPH) Announces Earnings Results, Beats Estimates By $0.11 EPS

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) issued its earnings results on Tuesday. The company reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.11, MarketWatch Earnings reports. Amphastar Pharmaceuticals had a return on equity of 17.35% and a net margin of 17.87%. During the same period last year, the […]

Related Keywords

China ,United States ,France ,Michaela Zasloff ,Piper Sandler ,Williamj Peters ,Amphastar Pharmaceuticals Company Profile Get Rating ,Securities Exchange Commission ,Earnings History For Amphastar Pharmaceuticals ,Zacks Investment Research ,Amphastar Pharmaceuticals Inc ,Commonwealth Of Pennsylvania Public School Empls Retrmt ,Amphastar Pharmaceuticals ,Wells Fargo Company ,Sei Investments Co ,Dimensional Fund Advisors ,Get Rating ,Marketwatch Earnings ,Investment Research ,Director Michael ,Exchange Commission ,Fund Advisors ,Pennsylvania Public School Empls Retrmt ,Pharmaceuticals Company Profile ,Finished Pharmaceutical Products ,Nasdaq Amph ,Amph ,Medical ,Earnings ,